208 related articles for article (PubMed ID: 36437050)
1. Cell-Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy.
Fan X; Wang K; Lu Q; Lu Y; Sun J
Small; 2023 Jan; 19(4):e2205166. PubMed ID: 36437050
[TBL] [Abstract][Full Text] [Related]
2. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
[TBL] [Abstract][Full Text] [Related]
3. Extracellular-Vesicle-Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer-Immunity Cycle.
Yong T; Wei Z; Gan L; Yang X
Adv Mater; 2022 Dec; 34(52):e2201054. PubMed ID: 35726204
[TBL] [Abstract][Full Text] [Related]
4. Exosomes as smart drug delivery vehicles for cancer immunotherapy.
Zhang H; Wang S; Sun M; Cui Y; Xing J; Teng L; Xi Z; Yang Z
Front Immunol; 2022; 13():1093607. PubMed ID: 36733388
[TBL] [Abstract][Full Text] [Related]
5. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
6. Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Zuo S; Song J; Zhang J; He Z; Sun B; Sun J
Theranostics; 2021; 11(15):7471-7487. PubMed ID: 34158861
[TBL] [Abstract][Full Text] [Related]
7. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy.
Shang Q; Dong Y; Su Y; Leslie F; Sun M; Wang F
Adv Drug Deliv Rev; 2022 Jun; 185():114308. PubMed ID: 35472398
[TBL] [Abstract][Full Text] [Related]
8. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
[TBL] [Abstract][Full Text] [Related]
10. Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects.
Chen Z; Kankala RK; Yang Z; Li W; Xie S; Li H; Chen AZ; Zou L
Theranostics; 2022; 12(8):3719-3746. PubMed ID: 35664074
[TBL] [Abstract][Full Text] [Related]
11. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
Aikins ME; Xu C; Moon JJ
Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
[TBL] [Abstract][Full Text] [Related]
12. The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
Leong A; Kim M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217955
[TBL] [Abstract][Full Text] [Related]
13. Strategies of Combination Drug Delivery for Immune Checkpoint Blockades.
Ruan H; Bu L; Hu Q; Cheng H; Lu W; Gu Z
Adv Healthc Mater; 2019 Feb; 8(4):e1801099. PubMed ID: 30548835
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Augmenting the synergies of chemotherapy and immunotherapy through drug delivery.
Kim J; Manspeaker MP; Thomas SN
Acta Biomater; 2019 Apr; 88():1-14. PubMed ID: 30769136
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
Liu J; Zhang R; Xu ZP
Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
18. Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape.
Raikwar S; Jain A; Saraf S; Bidla PD; Panda PK; Tiwari A; Verma A; Jain SK
Expert Opin Drug Deliv; 2022 Mar; 19(3):247-268. PubMed ID: 35184620
[TBL] [Abstract][Full Text] [Related]
19. Bioengineered nanogels for cancer immunotherapy.
Ma X; Li SJ; Liu Y; Zhang T; Xue P; Kang Y; Sun ZJ; Xu Z
Chem Soc Rev; 2022 Jun; 51(12):5136-5174. PubMed ID: 35666131
[TBL] [Abstract][Full Text] [Related]
20. Carrier-Free Nanomedicine for Cancer Immunotherapy.
Fu Y; Bian X; Li P; Huang Y; Li C
J Biomed Nanotechnol; 2022 Apr; 18(4):939-956. PubMed ID: 35854464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
